Spondyloepimetaphyseal dysplasia
Spondyloepimetaphyseal dysplasia (SEMD) is a group of rare genetic disorders that affect bone growth, particularly in the spine (vertebrae), the ends of long bones (epiphyses), and the bones of the hands and feet (metaphyses). These conditions are part of a larger group of disorders known as skeletal dysplasias, which are characterized by abnormalities in the size and shape of the limbs, trunk, and skull.
Causes[edit | edit source]
SEMD is caused by mutations in various genes that are important for the development and maintenance of bone and cartilage. These mutations are usually inherited in an autosomal recessive manner, meaning that an individual must inherit two copies of the mutated gene, one from each parent, to be affected. In some cases, SEMD can be inherited in an autosomal dominant pattern, where only one copy of the mutated gene is sufficient to cause the disorder.
Symptoms[edit | edit source]
The symptoms of SEMD can vary widely among affected individuals but generally include:
- Short stature, often with a short trunk
- Abnormal curvature of the spine (Scoliosis and/or Kyphosis)
- Abnormalities in the shape of the vertebrae
- Flattened bones at the ends of the long bones (epiphyses)
- Abnormal bone growth in the hands and feet
Other possible features include problems with vision and hearing, joint stiffness, and difficulties with mobility.
Diagnosis[edit | edit source]
Diagnosis of SEMD typically involves a combination of clinical examination, family history, and imaging studies such as X-rays, which can reveal characteristic abnormalities in bone structure. Genetic testing may also be performed to identify specific mutations causing the disorder.
Treatment[edit | edit source]
There is no cure for SEMD, but treatment is focused on managing symptoms and improving quality of life. This may include:
- Physical therapy to improve mobility and strength
- Orthopedic interventions, such as surgery, to correct bone deformities and improve function
- Pain management strategies
- Regular monitoring for potential complications, such as breathing difficulties due to chest wall deformities
Prognosis[edit | edit source]
The prognosis for individuals with SEMD varies depending on the severity of the symptoms and the specific genetic cause. While some individuals may experience significant physical limitations, others may lead relatively normal lives with appropriate management and support.
See also[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD